Pentavac

BIOLOGICAL2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, PATH

Conditions

Pneumonia, PneumococcalVaccines, Pneumococcal

Phase 1

Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers

CompletedNCT02097472

PATHPneumonia, Pneumococcal

Start: 2014-04-30End: 2015-12-31Updated: 2019-10-10

Phase 3

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants

CompletedNCT00366678

Wyeth is now a wholly owned subsidiary of PfizerVaccines, Pneumococcal

Start: 2006-10-31End: 2008-11-30Updated: 2012-08-15